ECOR
electroCore, Inc.
NASDAQ · USHealthcareMedical - Devices
$6.07+3.23%
Price as of Jul 20, 2026
ECOR growth
electroCore, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +31.9%
- EBITDA
- -18.4%
- EBIT
- -20.7%
- EPS
- -13.8%
- Free cash flow
- +21.8%
- Operating cash flow
- +21.8%
Forward estimates
- Revenue
- +47.9%
- EBITDA
- —
- EPS
- +86.8%
Three-year CAGR
- Revenue
- +55.1%
- EBITDA
- -9.1%
- EBIT
- -8.1%
- Net income
- -17.5%
- EPS
- -3.8%
- Free cash flow
- -18.8%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.